The move towards a more transparent regulatory regime in India is opening up its biopharma industry once again. With the widely available patient population and low manufacturing cost base, India remains an attractive destination for international biopharma players.
But there are still challenges – quality assurance and control concerns need to be addressed if India wants to supply into the world’s most lucrative international markets. R&D also needs to be strongly supported, fostering an environment of innovation and encouraging new biotech start-ups to develop cutting-edge solutions and products, and also attracting world-class talent home to India.
BioPharma India 2017 gives you the opportunity to meet the innovators in our Therapeutic Innovation & Partnering track, featuring exciting biotech companies pitching their products, pipelines and path to commercialisation.
Joining them will be leading biotech entrepreneurs, innovative start-ups and major pharma players from both within and outside India, together creating our most ambitious agenda ever, reflecting the huge opportunity in India’s biopharma industry. With case studies, innovation showcases and interactive panel discussions, you can meet and hear from the movers and shakers
For a 15% off on prices, please contact us on email@example.com
Tuesday, September 19, 2017 to Wednesday, September 20, 2017